Andrew Sinclair Selected Research

XX Disorders of Sex Development 46 (Female Pseudohermaphroditism)

1/2022	Two ovarian candidate enhancers, identified by time series enhancer RNA analyses, harbor rare genetic variations identified in ovarian insufficiency.
1/2016	Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Sinclair Research Topics

Disease

2	Gonadal Dysgenesis (Gonadal Agenesis) 01/2022 - 01/2016
2	XX Disorders of Sex Development 46 (Female Pseudohermaphroditism) 01/2022 - 01/2016
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2022
1	Hearing Loss (Hearing Impairment) 12/2021
1	Primary Ovarian Insufficiency 12/2021
1	Seizures (Absence Seizure) 12/2021
1	Intellectual Disability (Idiocy) 12/2021
1	Cryptorchidism (Undescended Testes) 11/2019
1	Myocardial Infarction 02/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Renal Insufficiency (Renal Failure) 11/2016
1	Stroke (Strokes) 11/2016
1	Aneurysm (Aneurysms) 11/2016
1	Septic Shock (Toxic Shock Syndrome) 11/2016
1	Cardiogenic Shock 11/2016
1	Neoplasms (Cancer) 04/2016
1	Neutropenia 01/2016
1	Poisoning 01/2016
1	Transfusion-Related Acute Lung Injury 01/2016
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 01/2016
1	Sex Chromosome Disorders of Sex Development 01/2016
1	Disorders of Sex Development (Intersexuality) 11/2014
1	Fatigue 04/2014
1	Prostatic Neoplasms (Prostate Cancer) 02/2014
1	Alcoholic Fatty Liver 01/2014
1	Metabolic Diseases (Metabolic Disease) 01/2014
1	Hepatomegaly 01/2014
1	Coronary Disease (Coronary Heart Disease) 04/2011
1	Insulin Resistance 04/2011
1	Thrombosis (Thrombus) 02/2011
1	Thrombocytopenia (Thrombopenia) 02/2011
1	Hemorrhage 02/2011

Drug/Important Bio-Agent (IBA)

2	HydrogelsIBA 01/2019 - 04/2014
1	NucleotidesIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2021
1	relaxin receptorsIBA 11/2019
1	Insulin (Novolin)FDA Link 11/2019
1	Peptide Receptors (Peptide Receptor)IBA 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 04/2016
1	PolymersIBA 04/2016
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2016
1	OrganophosphatesIBA 01/2016
1	inhibin BIBA 01/2016
1	ButyrylcholinesteraseIBA 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	Androstenedione (4 Androstene 3,17 dione)IBA 01/2016
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 01/2016
1	AndrogensIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 11/2014
1	CholesterolIBA 01/2014
1	Dietary CholesterolIBA 01/2014
1	Transaminases (Aminotransferases)IBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2011
1	CarbohydratesIBA 04/2011
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2011
1	AnticoagulantsIBA 02/2011
1	Heparin (Liquaemin)FDA LinkGeneric 02/2011

Therapy/Procedure

2	Therapeutics 04/2016 - 02/2014
1	Percutaneous Coronary Intervention 02/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2016
1	Heart-Assist Devices 11/2016
1	Drug Therapy (Chemotherapy) 04/2016
1	Castration 02/2014